P rotractedbacterialbronchitisisaclinicaldiagnosis, definedas'anisolatedchronicmoistcoughpersistingcontinuouslyformorethan4weekswithoutany clinicalfindingssuggestiveofanalternativediagnosisand resolutionofsymptomsinthemajoritywhenantibiotic therapy is given for at least 2 to 3weeks' (Chang et al, 2008) . When treatment fails, more detailed investigationsandatreatmentapproachsimilartothatfornoncystic fibrosis bronchiectasis are required. A systematic reviewencompassing989childrenwithnon-cysticfibrosis bronchiectasis identified an underlying disorder in 63% of children but in almost a third no identifiable pathology was found (Brower et al, 2014) . Whether unrecognized, untreated or frequently recurring protracted bacterial bronchitis leads to development of chronic suppurative lung disease and subsequent bronchiectasis (Chang et al, 2008; Verhagen and de Groot, 2015) isaquestionthatcanonlybeansweredbylongtermprospectivestudies.
The concept of protracted bacterial bronchitis is not newalthoughovertheyearsithasbeendescribedbydifferentterminologiessuchaschronicbronchitisofchildhood, protracted bronchitis, persistent endobronchial infectionorpre-bronchiectasis,allaimingtoreflectthe clinicalphenotype (Marchantetal,2008a; Cravenand Everard,2013) .Untilrecently,protractedbacterialbronchitishasremainedunderrecognizedandlargelyundiagnosed,withcasesofprotractedbacterialbronchitispresenting with chronic moist cough being attributed to otheraetiologies.Thisunder-recognitionmaybebecause healthprofessionalsarenotfamiliarwiththecondition ortheremaybeareluctancetoacceptthediagnosis (Paul and Hilliard 2014) . This often leads to these children being inappropriately treated as having 'asthma' with minimalornoimprovementinclinicalcondition.The ideaoftreatingrelativelywelllookingchildrenwithjust
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Paediatrics, Southmead Hospital, Bristol and Dr Jayesh M Bhatt is Consultant Respiratory Paediatrician, Nottingham Children's Hospital, Nottingham Correspondence to: Dr SP Paul (siba.paul@nhs.net) amoistcoughwithprolongedcoursesofantibioticsmay also lead to under-recognition and non-acceptance of thecondition. However,increasedavailabilityofadvanceddiagnostic proceduressuchasbronchoscopyanddemonstrationof different bacteria in bronchoalveolar lavage samples has ledtoabetterunderstandingofthepersistenceofalow gradebacterialinfectionintheconductingairwaysinan otherwisewellchild (CravenandEverard,2013; Pauland Hilliard,2014) .InclusionofthisconditionintheBritish Thoracic Society guidelines 'Recommendations for the assessmentandmanagementofcoughinchildren'should leadtoanincreasedawarenessofthecondition (Shields etal,2008) . Thisarticleoutlinestherecognitionandmanagement ofchildrenwithprotractedbacterialbronchitisanddiscusses the management of the small number of cases who fail to respond to or relapse after courses of oral antibiotics.
Differential diagnosis of moist cough in children
Chronic cough is a common presentation in children; some of these cases can be associated with serious pathologies.Thiscanbeanextremelydistressingsymptom and has a major impact on a child's activities of daily living, sleep and school performance. It is also associated with a high burden of recurrent medical attendances,parentalstressandanxiety (Marchantetal, 2008b) .Achronicmoistcoughisalwaysabnormaland representsexcessiveairwaysecretions,anditisthemost useful clinical marker in predicting specific cough (Changetal,2005) .However,achronicdrycoughmay represent a dry phase of an otherwise usually moist cough, or the airway secretions may be too little to influencethecoughquality.
Chronic and especially recurrent or persistent moist coughsecondarytosomeofthecauseslistedinTable 1 could indicate that bronchiectasis has developed, althoughtheaimshouldbetodetectearlyandaggressivelytreattopreventorreversebronchiectasis,challengingthebeliefthatbronchiectasisisirreversible (Eastham etal,2004 
Epidemiology of protracted bacterial bronchitis
Protracted bacterial bronchitis is not a new condition but is increasingly recognized as being a re-emerging condition (Craven and Everard, 2013 (Priftisetal,2013) .Astudyof104chil-dren with protracted bacterial bronchitis reported that childrenaffectedaretypicallypreschoolboys,withprolonged moist cough and parent-reported wheeze, who haveattendedchildcare (Wurzeletal,2014) .Theprevalence of protracted bacterial bronchitis in childhood is notexactlyknown;theuseofdifferentterminologiesto identifydifferentmeaningsinthespectrumofprotracted bacterialbronchitisalsomakesitverydifficulttogauge its true prevalence (Kompare and Weinberger, 2012) . However, when the symptom of chronic cough was evaluatedinastructuredmanner,between23and41% ofchildrenwithchroniccoughturnedouttohaveprotracted bacterial bronchitis (Asilsoy, 2008; Marchant et al,2008a; Changetal,2012) . Protractedbacterialbronchitisisachronicrespiratory infection that can occur in the 'well child' as well as thosewithpre-existingairwaydisease.Theprevalenceof protracted bacterial bronchitis in children with airway malacias is considerably higher than in children with normalairways (Wurzeletal,2014) .Astudyfromthe USA involving 70 children with protracted bacterial bronchitis found that tracheomalacia, bronchomalacia or both were present in 52 (74%) children (Kompare and Weinberger, 2012) . A hypothesis for this is that airwaycollapseinterfereswithnormalcephaladmucous flow, thus decreases the effectiveness of coughing and predisposestobacterialstasis (FahyandDickey,2010) . Itisunclear,however,whatcauseandeffectrelationship exists between airway malacia and protracted bacterial bronchitis -Moreno et al (2014) found that 28% of childrenwithmalaciahadprotractedbacterialbronchitis and76%ofchildrenwithprotractedbacterialbronchitis hadairwaymalacia.Thisalsoraisesaquestionaboutthe potential for chronic airway damage from protracted bacterialbronchitis.
Pathophysiology of protracted bacterial bronchitis
Bacteriallowerrespiratorytractinfectionscanbedifferentiated into two discrete clinical entities -infections thataffecttherespiratoryzoneofthelungvsinfections that affect the conducting airways (Priftis et al, 2013) . The larger respiratory zone contributes to 95% of lung volume and includes respiratory bronchioles, alveolar ducts and alveolar sacs. The smaller conducting zone includesthetrachea,bronchiandterminalbronchioles;it doesnotcontributetogaseousexchangeandistheanatomicaldeadspace.
Thepathophysiologyofprotractedbacterialbronchitis involves bacterial biofilm formation (in contrast to therapidlydividingplanktonicstateseeninacutepneumonia affecting the respiratory zone) (Priftis et al, 2013) .Biofilmisahighly-organizedmulticellularcommunity, encased in an extracellular polymeric matrix. Bacteria within biofilm tend to have a reduced growth rate and increased resistance not only to the host's immunesystembutalsotoantibiotics-antibioticstargetingthebacterialcellwallareineffectivebecauseofthe reduced replication rate. In addition, the polymeric matrixpresentsaphysicalbarriertocellulareffectorsof immunityandishighlyrecalcitranttoremoval (Bakaletz, 2012) .Thispathophysiologicalmechanismmayexplain whyroutine7-oreven14-daycoursesofantibioticsare often ineffective in treating children with protracted bacterialbronchitis.
Bronchoscopy and bronchoalveolar lavage cultures takenfromchildrenwithconfirmedprotractedbacterial bronchitis have provided an insight into the common bacterial pathogens. Typically non-typable Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalishavebeengrownseparatelyorincombination in various studies (Kompare and Weinberger, 2012; Marchant et al, 2012; Priftis et al, 2013; Narang et al, 2014) . H. influenzae was the commonest organism isolated and polymicrobial growth was common in up to 35% of patients (Marchant et al, 2012; Priftis et al, 2013) .
Bronchoalveolar lavage samples from children with protracted bacterial bronchitis also have significant airway neutrophilia (Kompare and Weinberger, 2012; Marchant et al, 2012; Wurzel et al, 2014) . Levels of inflammatorymediatorssuchasinterleukin8(IL-8)and active matrix metalloproteinase 9 (MMP-9) were both significantlyhigher(P<0.005)inpatientswithprotracted bacterial bronchitis than in controls (children whose coughresolvednaturally) (Marchantetal,2008a) .CD56 andCD16(naturalkillercells)levelswerealsohigherin children with protracted bacterial bronchitis (Wurzel et al,2014) .Thissuggeststhatprotractedbacterialbronchitis is associated with airway neutrophilia and a marked inflammatorymediatorresponsewithevidenceofinnate immunesystemactivation.
Clinical presentation of protracted bacterial bronchitis
Inastudyof81childrenwithprotractedbacterialbron-chitis from the UK, the most common initiating event wasanacutelowerrespiratorytractinfection(42%),with pneumoniaaccountingforafurther30% (Donnellyetal, 2007) .Thesamestudyrevealedtheinitialhistorygiven byparentsincludedpersistentcough(95%),shortnessof breath (43%), wheezing (48%), noisy breathing and exacerbation with upper respiratory tract infections (Donnellyetal,2007) .Inanotherstudyof104children fromAustralia,themediancoughdurationinprotracted bacterialbronchitiswas28weeks (Wurzeletal,2014) .
Thecoughhasbeentypicallydescribedasa'moist'or a'smoker'scough' (Donnellyetal,2007) .Aretrospec-©2015MAHealthcareLtd tivestudyreviewingthepresenceofairwaymalaciain childrendiagnosedwithprotractedbacterialbronchitis notedthatnonehadfeveroratoxicappearanceassociated with their respiratory symptoms (Kompare and Weinberger, 2012) . This suggests that children with protracted bacterial bronchitis suffer from respiratory symptoms but otherwise generally look well in themselves. This could partly account for the time delay from symptom onset to diagnosis -the 'watch and wait'ideology.
Infective exacerbations are an important feature of protractedbacterialbronchitis.Whileinfective(bacterial or viral) exacerbations of respiratory diseases such as asthma or cystic fibrosis are well known, viral-bacterial co-infectionisalsoacommonfeatureofprotractedbacterial bronchitis. One study reported that viruses were detected in nasopharyngeal aspirate of 85% of patients withprotractedbacterialbronchitis (Wurzeletal,2014) . During an infective exacerbation, children will often experienceanincreaseinsymptomsforaperiodoftime and then regress back to the baseline level (Craven and Everard,2013) .Thesecondarysuperimposedinfectionis thoughttocausethereleaseofplanktonicbacteriafrom theestablishedbiofilm(likelyinresponsetotheassociatedinflammation)asseeninpatientswithcysticfibrosis (Høiby,2002) .
History and examination
Thediagnosisofprotractedbacterialbronchitisremains aclinicalone.Thefirstandmostvitalstepistoconfirm thehistoryfromparents.Specificinformationshouldbe soughtonthedurationofcoughandnoisybreathing,the natureofthecough(i.e.dryormoist),thatthecoughis actuallypersistentandchronic(i.e.notdifferentepisodes occurring back to back with symptom-free periods in between), and therapies used so far (e.g. inhaled bronchodilators or steroids for asthma, often without any actual benefit) including whether any antibiotics have beenused (PaulandHilliard,2014) . A study from the UK with 47 children (median age 26months)identifiedbacterialbronchitisin43%ofchil-dren with persistent wheeze having received optimal treatmentforasthma(24%werereceivingoralsteroids) (Saglanietal,2006) .Thesamestudyalsoidentifiedcoexisting gastro-oesophageal reflux and positive bacterial cultures in a significant number of children, the most likelyexplanationbeingaspirationleadingtodisruption ofthenormalepitheliumandcolonizationbyorganisms such as H. influenzae (Saglani et al, 2006) . Even when DNA-based methods were used, strikingly similar core respiratorymicrobiotawereseenincommonchildhood airway pathologies and this is likely shaped by natural aspiration and impaired clearance of the same airway microbes (VanderGastetal,2014) .However,longitudinalandinterventionalstudiesarerequiredtodefinethe relationshipsbetweenmicrobiota,treatmentsanddisease progression.
Once the history raises a clinical suspicion of protractedbacterialbronchitis,thechildshouldbereferred toapaediatriciantoestablishthediagnosisandexplain the condition to the parents. It is also important to exclude other possible causes which will be largely dependentonthehistoryandexaminationwhileinvestigations will help rule out other conditions. Other coexisting conditions such as airway malacias make the childpronetofrequentrespiratoryexacerbationsanditis importanttodecidewhetherthedeterioratingrespiratory symptomsaretheresultoftheprimaryillnessorwhether protracted bacterial bronchitis is exacerbating the primaryillness.Thisisdifficultandactionswilllargelybe basedonanindividualclinicalassessment,butprotracted bacterial bronchitis should be considered in any child withtroublesomerespiratorysymptoms.
The history should be followed by a detailed clinical examination.Thephysicalexaminationincludingauscultationofthechestwillusuallybenormalalthoughthisis necessarytoruleoutotherdifferentialdiagnoses.Rattles (heardwithorwithoutstethoscope)andfeltasvibrations onpalpationofthechestareoftenfoundduringanacute episode -this noise is often mislabelled as wheeze by parents and some health professionals (Craven and Everard,2013) .
Investigations and diagnosis
Thepatternsofsymptomsfoundinprotractedbacterial bronchitisarenotuniquetotheconditionandarecommonly seen in all differentials of protracted bacterial bronchitis( Table 1) .Whenevaluatingpatientswithrespiratorysymptoms,onesuggestionistousetheacronym SPUR(severe,persistent,unusual,recurrent)toprompt consideration of further investigations for underlying causesofrespiratorysymptoms (Jesenaketal,2011) .In addition, symptoms being unresponsive to treatment, suchasacoughnotrespondingtoinhaledororalcorticosteroids,shouldtriggerconsiderationofanalternative diagnosis.
Protracted bacterial bronchitis is a clinical diagnosis made on assessment of response to treatment of moist coughwithantibiotics.Areasonableapproach,suggested intheliteratureandfromtheauthors'clinicalexperience, istoexplaintheclinicaldiagnosisandgiveatrialoforal antibiotics.Itisimportant,however,toexplaintoparents thatthisapproachmaynotconfirmadefinitivediagnosis butminimizestheriskfrominvasiveinvestigationssuch as bronchoscopy and associated general anaesthesia (Kompare and Weinberger, 2012; Craven and Everard, 2013) .
Investigations should generally be reserved for cases wherethechildremainsunresponsivetoprolongedcourse ofantibioticsoriftherehavebeenmorethantworelapses of protracted bacterial bronchitis (Donnelly et al, 2007; PaulandHilliard,2014) .Chestradiographsmaybeperformed in children with protracted bacterial bronchitis andaregenerallynormalalthoughsomemayshowperi-bronchialthickening (Marchantetal,2008b; Changetal, 2012) . However, chest radiographs can provide useful informationinchildrenwithchroniccoughifthediagnosis is unclear (Donnelly et al, 2007; Bakaletz, 2012) . High-resolution computed tomography may be helpful wherecoexistentanatomicalorlungmalformations(e.g. congenitalcysticadenomatoidmalformation)orretained foreignbodiesaresuspected (Donnellyetal,2007; Shields etal,2008) .Asputumcultureorcoughswabmaybesent inolderchildrenbutmicrobiologicalyieldisusuallylow (Shieldsetal,2008; Changetal,2012) .
Diagnosis of protracted bacterial bronchitis can be confirmedbybronchoscopywithbronchoalveolarlavage followed by microbiological studies; however, such an invasive approach may not be necessary in most cases. Moreover,thetechnicalexpertiseandfacilitiesforpaediatricgeneralanaesthesiaandbronchoscopyareoftenonly available in specialist centres (Paul and Hilliard, 2014) . Bronchoscopywithbronchoalveolarlavagemaybeconsideredincaseswhererelapseisseenafterthreecoursesof prolongedoralantibioticsorifthereisastronginsistence fromparentsforadefinitivediagnosisattheveryoutset (CravenandEverard,2013) . A retrospective review of 50 children with protracted bacterial bronchitis in the UK suggested that multiple lobes should be sampled for bronchoalveolar lavage at bronchoscopy (as per the European Respiratory Society guidance)asorganismsarelikelytobemissedifasample istakenfromasinglelobeonly (Narangetal,2014) .The bronchoalveolar lavage sample sent for microbiological studiesislikelytogrowbacterialspecies,non-typableH. influenzae and S. pneumoniae being most commonly documentedinstudies (KompareandWeinberger,2012; Marchant et al, 2012; Priftis et al, 2013; Wurzel et al, 2014) . Microbiological confirmation will allow use of antibioticstowhichtheisolateissensitiveandislikelyto allow better resolution in resistant cases already treated withusualantibiotics.Bronchoscopywillalsohelpdocumentthepresenceorotherwiseofairwaymalacia.
In children requiring repeated courses of antibiotics, furtherinvestigationsshouldbeconsidered.Thisincludes totalimmunoglobulinsG,A,MandE,specificantibodies against H. influenzae B (Hib) and S. pneumoniae, sweattestsandciliarystudies.Inaretrospectivestudyof 81childrenwithaclinicaldiagnosisofprotractedbacte-rialbronchitis,furtherinvestigationswerecarriedoutin childrenwhorequiredmorethantwocoursesofantibiotics. One-third of these children had specific antibody levelsagainstHib,tetanusandS. pneumoniaemeasured. Suboptimalspecificantibodylevelswerecommonlyseen, butalmostalllevelsreturnedtonormalafterrevaccination (Donnellyetal,2007) . Incontrast,Limetal(2012) found that 14 out of 24 (58%) children with chronic moist cough failed to mount an adequate antibody response to booster immunization against Hib and S. pneumoniae,consistentwithspecificpolysaccharideantibodydeficiency.Thisraisesthequestionofwhetherineffectivevaccine-relatedantibodystatusormissedvaccinationscanincreasesusceptibilitytodevelopingprotracted bacterialbronchitis.However,theH. influenzaedetected inpreviouslyimmunizedchildrenwithprotractedbacterialbronchitisareoftenthenon-typablestrains (Craven and Everard, 2013) , which are not covered by the Hib vaccine.
Treatment
Treatment with prolonged courses of oral antibiotics is requiredtoeradicatetheformationofbacterialbiofilmin childrenwithprotractedbacterialbronchitis,thusallowingtimeforregenerationofepitheliumintheabsenceof infection (Changetal,2012) .Thereisalackofevidence regardingtheoptimaldurationofantibiotictherapythat will allow mucociliary clearance (Craven and Everard, 2013) .TheBritishThoracicSocietyrecommendstheuse of oral antibiotics in children with protracted bacterial bronchitisfor4-6weeks (Shieldsetal,2008) .Areview byCravenandEverard(2013)suggestedusinganempiricalcourseoforalantibioticsfor6-8weeks. A double-blind randomized controlled study from Australiainvolving50childrenwithprotractedbacterial bronchitis (moist cough of at least 3weeks' duration) showed that antibiotic therapy with co-amoxiclav for 2weeks led to resolution of cough in 48% of children compared to only in 16% in children who received a placebo (Marchantetal,2012) .Theauthors'practiceis touse3weeksoforalantibioticsfollowedbyareviewat theendoftheantibiotictherapy.
As most cases of protracted bacterial bronchitis are treated on clinical suspicion, the most commonly used empiricalantibioticisoralco-amoxiclav (Marchantetal, 2012) . A Cochrane review of treatment of acute lower respiratory tract infections (Laopaiboon et al, 2015) foundnosignificantdifferenceintheincidenceofclinicalfailureondays10-14withazithromycin,amoxicillin orco-amoxiclavbutasubgroupanalysisshowedthattrials with acute bronchitis participants had significantly lowerlevelsofclinicalfailureinthosetakingazithromycin.Azithromycinhasadefinitedosingbenefit(administered only once a day) and fewer adverse effects (Laopaiboonetal,2015) .Althoughazithromycinisnot more effective in treating lower respiratory tract infections it is particularly useful in those with a penicillin allergy and in younger children for dosage benefit (9 dosesofazithromycinvs63dosesofco-amoxiclavfora 21-daycourse) (PaulandHilliard,2014) .
Itisimportanttoensurethatthechildhoodimmunizationsareuptodate,evenmoresoinchildrenwithpredisposingriskfactorsfordevelopingprotractedbacterial bronchitis. Patients who had been vaccinated were 50 timeslesslikelytoisolateapneumococcalvaccineconjugate serotype from bronchoalveolar lavage (Priftis et al, 2013) .
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Management of children with protracted bacterial bronchitis who fail to respond to initial treatment
Persistent moist cough and failure to respond or relapse afterthreecoursesoforalantibiotics(of2-3weeks'duration) should lead to consideration of a high-resolution computedtomographyscanandbronchoscopicassessment (Paul and Hilliard, 2014) . A high-resolution computed tomography scan will identify bronchiectatic changes in the lungs and help decide on further management. Evidence of chronic suppurative lung disease or airway malaciasmaybefoundduringbronchoscopicassessment, andbronchoalveolarlavagesamplesshouldbetakenfrom multiplelobesandsentformicrobiologicalandcytological studies (Narang et al, 2014) . The choice of intravenous antibioticsshouldbeguidedbythegrowth of organisms andsensitivitiesofthebronchoalveolarlavagesample;the durationmayvarybetween4and6weeks.Agoodresponse tointravenousantibioticsreducesthelikelihoodofdevelopingbronchiectasisinthelongtermalthoughitdoesnot excludethepossibilitycompletely (Goyaletal,2014) . Treatmentofrecurrentepisodesofprotractedbacterial bronchitis is still based on extrapolation of treatment approachestochronicsuppurativelungdiseaseandestablished non-cystic fibrosis bronchiectasis. This includes maintenance azithromycin therapy for up to 24months whichleadstodecreasedpulmonaryexacerbationsinchildren with non-cystic fibrosis bronchiectasis or chronic suppurativelungdisease.However,thiscancauseincreased carriage of azithromycin-resistant bacteria, the clinical consequencesofwhichareuncertain,andwillneedcarefulmonitoringandfurtherstudy (Valeryetal,2013; Gao et al, 2014) . While many knowledge gaps and management challenges remain, the future is improving for patientswithbronchiectasis (Grimwoodetal,2014) .
Prognosis
Untreatedcasesmayveryrarelyhavenaturalresolutionof theircoughbutthevastmajoritywillrequireprolonged courses of antibiotics to treat troublesome symptoms. Thenaturalhistoryofuntreatedorfrequentlyrecurrent protractedbacterialbronchitisremainsunknown.Longterm prospective follow-up studies are needed to determine whether untreated or frequently recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis are different conditions with overlappingsymptomsorreflectseverityaspartofaspectrum (Changetal,2008) .
The outcome for children with protracted bacterial bronchitis treated with antibiotics is generally good. A retrospectivelong-termreviewof44childrenwithcon-firmeddiagnosisofprotractedbacterialbronchitisfound that 33 (75%) children achieved complete resolution withantibioticsand10hadincompleteresolutionwith prolongedcoursesofantibiotics (Pritchardetal,2015) . Fivechildrenweretreatedorinvestigatedforotherrespiratory conditions, three of whom were diagnosed with asthma and started on corticosteroids (Pritchard et al, 2015) . Another review of 81 children with a clinical diagnosis of protracted bacterial bronchitis (only a minority had bronchoalveolar lavage) found that 41 (51%)childrenweresymptomfreeaftertwocoursesof antibiotics,although13%of41childrenwithprotract-edbacterialbronchitisrequired≥6coursesofantibiotics (Donnellyetal,2007) .Childrenwithspecificpolysaccharideantibodydeficiencyweremorelikelythanchildren with normal antibody responses to require intravenous antibiotics and to have abnormal chest radiographs (Limetal,2012) . Whileawatchandwaitapproachisjustifiablewhen managingchildrenwithchronicdrycoughwithoutany cough pointers, the same does not apply for children with chronic moist cough (Chang et al, 2015) . Emerging evidence from randomized controlled trials supports treatment of initial episodes of protracted bacterialbronchitiswithatleast2-week-longcoursesof oral antibiotics (Marchant et al, 2012) and failure to respond to a 4-week course of appropriate antibiotics increasesthelikelihoodofbronchiectasisbeingdetectedonhigh-resolutioncomputedtomography (Goyalet al,2014) .
KEY POINTS
n Protracted bacterial bronchitis should be considered in any child who has an isolated chronic moist cough persisting continuously for more than 4 weeks.
n Airway malacia is associated with protracted bacterial bronchitis.
n Prolonged courses of antibiotics are necessary to treat protracted bacterial bronchitis.
n Recurrent episodes of protracted bacterial bronchitis should lead to a thorough investigation for possible underlying serious causes of chronic moist cough in children.
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